HGEN - $GILD has a problem in severe COVID - “ WHO Director General Tedros Adhanom Ghebreyesus defended the so-called Solidarity Trial, which was launched to study the effectiveness of remdesivir and three other drugs in treating COVID-19, as the largest trial in the world. It included more than 11,000 coronavirus patients across 30 countries, with more than 2,700 participants given remdesivir.” No Benefit.
AND they have access to UNblinded HGEN - Lenzilumab-Yescarta data - Cytokine storm In CAR-T is Cytokine storm in COVID- O’Day can treat two storms with one deal.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.